These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38834164)

  • 1. Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy.
    Griñán-Ferré C; Bellver-Sanchis A; Guerrero A; Pallàs M
    Pharmacol Res; 2024 Jul; 205():107247. PubMed ID: 38834164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoepigenetics and Pharmacoepigenomics: An Overview.
    Peedicayil J
    Curr Drug Discov Technol; 2019; 16(4):392-399. PubMed ID: 29676232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoepigenetics: an element of personalized therapy?
    Majchrzak-Celińska A; Baer-Dubowska W
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):387-398. PubMed ID: 27860490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Methylation Regulation in Neurodegenerative Disorders.
    Basavarajappa BS; Subbanna S
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenomic networking in drug development: from pathogenic mechanisms to pharmacogenomics.
    Cacabelos R
    Drug Dev Res; 2014 Sep; 75(6):348-65. PubMed ID: 25195579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of mitochondrial function in neurodegenerative disease: New insights from advances in genomic technologies.
    Devall M; Roubroeks J; Mill J; Weedon M; Lunnon K
    Neurosci Lett; 2016 Jun; 625():47-55. PubMed ID: 26876477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic programming of neurodegenerative diseases by an adverse environment.
    Babenko O; Kovalchuk I; Metz GA
    Brain Res; 2012 Mar; 1444():96-111. PubMed ID: 22330722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of epigenetics in personalized medicine: challenges and opportunities.
    Rasool M; Malik A; Naseer MI; Manan A; Ansari S; Begum I; Qazi MH; Pushparaj P; Abuzenadah AM; Al-Qahtani MH; Kamal MA; Gan S
    BMC Med Genomics; 2015; 8 Suppl 1(Suppl 1):S5. PubMed ID: 25951941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases.
    Zhang L; Liu Y; Lu Y; Wang G
    Biochem Pharmacol; 2022 Dec; 206():115295. PubMed ID: 36241096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodegeneration and epigenetics: A review.
    Ghosh P; Saadat A
    Neurologia (Engl Ed); 2023; 38(6):e62-e68. PubMed ID: 37344098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenomics, Pharmacoepigenomics, and Personalized Medicine in Cervical Cancer.
    Kabekkodu SP; Chakrabarty S; Ghosh S; Brand A; Satyamoorthy K
    Public Health Genomics; 2017; 20(2):100-115. PubMed ID: 28521327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers.
    Lopomo A; Coppedè F
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):49-62. PubMed ID: 28856927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in epigenetics and epigenomics for neurodegenerative diseases.
    Qureshi IA; Mehler MF
    Curr Neurol Neurosci Rep; 2011 Oct; 11(5):464-73. PubMed ID: 21671162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoepigenomics: a key determinant in resolving epigenomic parameters in pathogenesis and treatment response in complex diseases.
    Banerjee M
    Pharmacogenomics; 2022 Jan; 23(2):81-84. PubMed ID: 34842441
    [No Abstract]   [Full Text] [Related]  

  • 15. Moving pharmacoepigenetics tools for depression toward clinical use.
    Hack LM; Fries GR; Eyre HA; Bousman CA; Singh AB; Quevedo J; John VP; Baune BT; Dunlop BW
    J Affect Disord; 2019 Apr; 249():336-346. PubMed ID: 30802699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug Response.
    Cacabelos R; Torrellas C
    Int J Mol Sci; 2015 Dec; 16(12):30483-543. PubMed ID: 26703582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Medicine in Neurodegenerative Diseases: Some Promising Tips Coming from the microRNAs' World.
    Nuzziello N; Ciaccia L; Liguori M
    Cells; 2019 Dec; 9(1):. PubMed ID: 31892254
    [No Abstract]   [Full Text] [Related]  

  • 18. Epigenetic Regulation in Neurodegenerative Diseases.
    Berson A; Nativio R; Berger SL; Bonini NM
    Trends Neurosci; 2018 Sep; 41(9):587-598. PubMed ID: 29885742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of epigenetics in kidney cell biology.
    Li LX; Agborbesong E; Zhang L; Li X
    Methods Cell Biol; 2019; 153():255-278. PubMed ID: 31395383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spermidine as an epigenetic regulator of autophagy in neurodegenerative disorders.
    Satarker S; Wilson J; Kolathur KK; Mudgal J; Lewis SA; Arora D; Nampoothiri M
    Eur J Pharmacol; 2024 Sep; 979():176823. PubMed ID: 39032763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.